For: | Korn WM. Moving toward an understanding of the metastatic process in hepatocellular carcinoma. World J Gastroenterol 2001; 7(6): 777-778 [PMID: 11854899 DOI: 10.3748/wjg.v7.i6.777] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i6/777.htm |
Number | Citing Articles |
1 |
Ying-cheng Lin, Ming-Yao Wu, De-Rui Li, Xian-Ying Wu, Rui-Ming Zheng. Prognostic and clinicopathological features of E-cadherin, α-catenin, β-catenin, γ-catenin and cyclin D<sub>1</sub> expression in human esophageal squamous cell carcinoma. World Journal of Gastroenterology 2004; 10(22): 3235-3239 doi: 10.3748/wjg.v10.i22.3235
|
2 |
Mohamed S. Othman, Ahmed M. Aref, Amal A. Mohamed, Wesam A. Ibrahim. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients. ISRN Hepatology 2013; 2013: 1 doi: 10.1155/2013/412317
|
3 |
Mohamed T. Abdel Aziz, Dawlat El-Miligy, Mona A. Amin, Amina El Ansari, Hanan H. Ahmed, Samer Marzouk, Dina Sabry. Molecular evaluation of apoptotic versus antiapoptotic angiogenic markers in hepatocellular carcinoma. Clinical Biochemistry 2008; 41(12): 1008 doi: 10.1016/j.clinbiochem.2008.02.005
|
4 |
M. Waheed Roomi, Nusrath W. Roomi, Tatiana Kalinovsky, Aleksandra Niedzwiecki, Matthias Rath. Micronutrient Synergy in the Fight against Hepatocellular Carcinoma. Cancers 2012; 4(2): 323 doi: 10.3390/cancers4020323
|
5 |
Lun-Xiu Qin, Zhao-You Tang. The prognostic molecular markers in hepatocellular carcinoma. World Journal of Gastroenterology 2002; 8(3): 385-392 doi: 10.3748/wjg.v8.i3.385
|
6 |
Cheon-Soo Park, Dae-Woon Eom, Yongchel Ahn, Hyuk Jai Jang, Shin Hwang, Sung-Gyu Lee. Can heme oxygenase-1 be a prognostic factor in patients with hepatocellular carcinoma?. Medicine 2019; 98(26): e16084 doi: 10.1097/MD.0000000000016084
|
7 |
Konstantinos Kourelis, Terina Chen, Alan Shikani. Metastatic hepatoma of maxillary sinus with atypical presentation. ANZ Journal of Surgery 2012; 82(7-8): 555 doi: 10.1111/j.1445-2197.2012.06119.x
|
8 |
Shilu Mathew, Ashraf Ali, Hany Abdel-Hafiz, Kaneez Fatima, Mohd Suhail, Govindaraju Archunan, Nargis Begum, Syed Jahangir, Muhammad Ilyas, Adeel G.A. Chaudhary, Mohammad Al Qahtani, Salem Mohamad Bazarah, Ishtiaq Qadri. Biomarkers for virus-induced hepatocellular carcinoma (HCC). Infection, Genetics and Evolution 2014; 26: 327 doi: 10.1016/j.meegid.2014.06.014
|
9 |
Pranathi Pappu, Urvashi Vijay, Dhatri Madduru, Ngalah Bidii Stephen, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 281 doi: 10.1016/B978-0-323-98807-0.00005-3
|
10 |
Shinji Osada, Masayuki Kanematsu, Hisashi Imai, Satoshi Goshima, Yasuyuki Sugiyama. Evaluation of Extracellular Signal Regulated Kinase Expression and Its Relation to Treatment of Hepatocellular Carcinoma. Journal of the American College of Surgeons 2005; 201(3): 405 doi: 10.1016/j.jamcollsurg.2005.05.015
|
11 |
Wei Wang, Lian-Yue Yang, Zhi-Li Yang, Gen-Wen Huang, Wei-Qun Lu. Expression and significance of RhoC gene in hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(9): 1950-1953 doi: 10.3748/wjg.v9.i9.1950
|
12 |
Kevin T.P. Ng, Terence K.W. Lee, Qiao Cheng, Jana Y.H. Wo, Chris K.W. Sun, Dong‐Yong Guo, Zophia X. Lim, Chung‐Mau Lo, Ronnie T.P. Poon, Sheung‐Tat Fan, Kwan Man. Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1. International Journal of Cancer 2010; 127(4): 859 doi: 10.1002/ijc.25105
|
13 |
N Hasan, M Mukim, P Sharma, U. S. Baghel, M. Khalid. CURRENT UPDATES ON DIAGNOSTIC BIOMARKERS OF HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 2019; 56(06): 7 doi: 10.53879/id.56.06.11625
|
14 |
Wen-Hua Xiao, Wei-Wen Liu. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(3): 376-380 doi: 10.3748/wjg.v10.i3.376
|
15 |
Yu-Jun Li, Xiang-Rui Ji. Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer. World Journal of Gastroenterology 2003; 9(2): 368-372 doi: 10.3748/wjg.v9.i2.368
|
16 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
|
17 |
Soon Sun Kim, Hyo Jung Cho, Je Hwan Won, Jae Ik Bae, Dae Ryong Kang, Jung-Dong Lee, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Jai Keun Kim, Jei Hee Lee, Seon Joo Ahn, Ju Han Park, Sung Won Cho, Jae Youn Cheong. Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. Cytokine 2015; 76(2): 449 doi: 10.1016/j.cyto.2015.07.001
|
18 |
Tara Behne, M. Sitki Copur. Biomarkers for Hepatocellular Carcinoma. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/859076
|
19 |
Peng Shang, Ai-Rong Qian, Tie-Hong Yang, Min Jia, Qi-Bing Mei, Chi-Hin Cho, Wen-Ming Zhao, Zhi-Nan Chen. Experimental study of anti-tumor effects of polysaccharides from <italic>Angelica sinensis</italic>. World Journal of Gastroenterology 2003; 9(9): 1963-1967 doi: 10.3748/wjg.v9.i9.1963
|
20 |
Lian-yue Yang, Wei-qun Lu, Geng-wen Huang, Wei Wang. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma. BMC Cancer 2006; 6(1) doi: 10.1186/1471-2407-6-110
|
21 |
Nikita Sehgal, Ruchi Jakhmola Mani, Nitu Dogra, Deepshikha Pande Katare. Biosensor Based Advanced Cancer Diagnostics. 2022; : 97 doi: 10.1016/B978-0-12-823424-2.00009-0
|
22 |
Mausumi Bharadwaj, Gaurav Roy, Koushik Dutta, Mohammad Misbah, Mohammad Husain, Showket Hussain. Tackling hepatitis B virus-associated hepatocellular carcinoma—the future is now. Cancer and Metastasis Reviews 2013; 32(1-2): 229 doi: 10.1007/s10555-012-9412-6
|